IQV

IQVIA Holdings
D

IQV

197.420
USD
5.89
(3.08%)
Market Closed
Volume
209,373
EPS
11
Div Yield
-
P/E
26
Market Cap
35,831,730,000
Related Instruments
    ICXUSD
    ICXUSD
    0.01626
    (10.27%)
    0.13500 USD
    C
    CRL
    3.720
    (2.04%)
    185.790 USD
    D
    DGX
    1.570
    (1.04%)
    153.100 USD
    I
    ICLR
    3.020
    (1.48%)
    207.680 USD
    L
    LH
    1.670
    (0.74%)
    228.660 USD
    P
    PRA
    -0.090
    (-0.57%)
    15.740 USD
    Q
    QGEN
    0.340
    (0.77%)
    44.660 USD
    More
News

Title: IQVIA Holdings

Sector: Healthcare
Industry: Diagnostics & Research
IQVIA is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.